What is the latest on Ozempic and Ozempic like drugs #ozempic #glp1
Dr. Ron Najafi discusses how Ozempic and similar GLP-1 drugs work in the brain to reduce cravings and appetite. They lower dopamine activation in the nucleus accumbens and have shown promise reducing alcohol consumption in some studies, addressing a clinical need since obesity causes severe illness and death.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet
Bill Wilson MD: Doctors Lack Metabolic Training. Ultra-Processed Foods Get Subsidized Over Real food